You're invited to a panel discussion on the innovative MedTech landscape in Australia and the scope for collaboration with the French ecosystem.
From investment to implementation, through research to commercial applications, our expert panellists will share their perspectives of the MedTech ecosystem on what it takes to build the next unicorn.
This event is the result of inspiring collaboration with the Australian-French Association for Research and Innovation (AFRAN) and the French National Centre for Scientific Research (known as CNRS).
The panel discussion will be followed by a cocktail networking session open by Francois de Meneval, French Tech AU Co-President.
Join us in exploring new ideas and creating meaningful connections that will leave a lasting impact. (Please note this event has limited capacity.)
Opening
-----
Australian Market Insights
Financing innovation
Dr David Nayagam, Executive Director Healthcare Research at E&P | Medtech Commercialisation
Market access and commercial adoption: a comparison between Australia and France
Enabling Medtech Innovation
-----
Panel discussion - Startup stories - DO & DON'T!
-----
About French Tech AU
Our mission is to create connections between startups, entrepreneurs, investors, corporates and community builders. French Tech AU is working under the responsibility of The French Tech Mission, which was set up in 2013 to support the structuring and growth of the French start-up ecosystem, both in France and internationally.
This event is innovatively sponsored by:
CCRM Australia: CCRM Australia is a Hub of the successful Centre for Commercialization of Regenerative Medicine (CCRM) in Canada. Established as a not-for-profit with a national focus, CCRM Australia’s mission is to address bottlenecks in the translation and commercialisation of cell and gene discoveries in Australia, many of which have the potential to cure devastating and costly diseases in the world today.
CNRS: The CNRS is a major player in research on the global stage and the only organisation in France that is active in all fields of science. Its unique position as a specialist in multiple fields means that it can bring together different disciplines and gain insight into current global challenges.
Pearce IP: Pearce IP is a boutique life sciences focussed firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys. Our service includes all aspects of contentious and non-contentious IP with a special focus on med-tech. Strategic thinking with a global focus is what we do best.
Laboratoire Servier: Servier is a privately owned pharmaceutical company governed by a non-profit foundation, and committed to therapeutic progress to serve patient needs. Servier has a long-standing commitment to research and development with over 20% of branded product turnover reinvested into R&D worldwide. Servier Australia also serves as a key member of the APAC Clinical Operations Hub.
